Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC) …………… Dhanasekaran R, Gabay-Ryan M, Baylot V, Lai I, Mosley A, Huang X, Zabludoff S, Li J, Kaimal V, Karmali P, Felsher DW. Oncotarget. 2017 Nov 9;9(5):5517-5528. PubMed 00
DNA mismatch repair and oligonucleotide end-protection promote base-pair substitution distal from a CRISPR/Cas9-induced DNA break …………… Harmsen T, Klaasen S, van de Vrugt H, Te Riele H. Nucleic Acids Res. 2018 Feb 13. PubMed 00
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing …………… Finn JD, Smith AR, Patel MC, Shaw L, Youniss MR, van Heteren J, Dirstine T, Ciullo C, Lescarbeau R, Seitzer J, Shah RR, Shah A, Ling D, Growe J, Pink M, Rohde E, Wood KM, Salomon WE, Harrington WF,…
CRISPR RNAs trigger innate immune responses in human cells …………… Kim S, Koo T, Jee HG, Cho HY, Lee G, Lim DG, Shin HS, Kim JS. Genome Res. 2018 Feb 22. PubMed 00